SRIT India IPO Opens with 12% Premium Indicated by GMP
SRIT India IPO Opens with 12% Premium Indicated by GMP
The initial public offering (IPO) of SRIT India Ltd kicked off with promising signals as the grey market premium (GMP) emerged around 12%, indicating strong investor interest ahead of the subscription period. This IPO is notable for investors tracking emerging IT and technology integration companies in India.
About SRIT India and Its IPO Details
SRIT India Ltd is an established player offering extensive IT and IT-enabled services specializing in turnkey technology integration projects. The company has a solid footing in sectors such as government technology (GovTech), healthcare technology (HealthTech), and telecommunications. SRIT India has won significant contracts recently, including projects involving 4G LTE connectivity for automated teller machines and digital transformation initiatives for various government bodies.
The IPO opened on September 28 and will close on September 30. It aims to raise approximately ₹218.4 crore through a fresh issue of shares, offering around 1.68 crore equity shares. The price band has been set between ₹123 and ₹130 per share, with a lot size of 115 shares, making the minimum investment about ₹14,950.
Market Reception and Grey Market Premium Insights
The GMP around 12% indicates that the IPO shares are currently expected to list at a premium on stock exchanges after the allotment. This premium reflects investor optimism about SRIT India’s business model and growth prospects, especially given its strong order book and government-backed contracts.
Market watchers view the robust GMP as a positive sign, often suggesting that subscription rates could be higher than the base due to favorable investor sentiment. However, it is important for investors to monitor formal subscription levels and allotment updates scheduled for October 1, with listing expected on October 6.
Use of IPO Proceeds and Strategic Importance
SRIT India plans to utilize the funds primarily to modernize its product offerings, strengthen working capital, and support strategic growth initiatives including possible acquisitions. This aligns with the company’s intent to continue expanding its technological capabilities and broadening its suite of digital solutions across multiple sectors.
The company’s recent accolades and projects, such as implementing unified health insurance solutions and upgrading forensic science laboratories, highlight its role as a key government technology integrator. This positions SRIT India well for sustained growth in expanding digital infrastructure sectors.
What Investors Should Watch Next
As the IPO subscription period closes, investors should closely monitor subscription statistics across retail, institutional, and non-institutional categories. The allotment results due on October 1 will provide clearer insights into market demand. The company’s performance post-listing, including stock price movement and operational updates, will be critical to assess the longer-term investment potential.
Additionally, tracking SRIT India’s contract wins, revenue growth, and strategic partnerships will help investors evaluate how effectively the company leverages the IPO proceeds for growth.
Overall, the SRIT India IPO attracts attention not only for its attractive GMP and price band but also for its positioning in key technology-driven sectors with strong government linkages. Investors looking at tech IPOs in India may find SRIT India a noteworthy opportunity to consider based on forthcoming subscription and market developments.

